相似文献/References:
[1]贺肴,张弛,刘瑛,等.代谢正常肥胖合并非酒精性脂肪性肝病的临床特征及内皮功能研究[J].国际内分泌代谢杂志,2015,(03):163.[doi:10.3760/cma.j.issn.1673-4157.2015.03.005]
He Yao,Zhang Chi,Liu Ying,et al.Clinical features and endothelial function in metabolically healthy obese patients with nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2015,(04):163.[doi:10.3760/cma.j.issn.1673-4157.2015.03.005]
[2]邵金双,邸阜生.网膜素抗炎作用及与代谢相关疾病的关系[J].国际内分泌代谢杂志,2014,(01):29.[doi:10.3760/cma.j.issn.1673-4157.2014.01.008]
Shao Jinshuang*,Di Fusheng ..Anti-inflammatory effect of omentin and its relationship with metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(04):29.[doi:10.3760/cma.j.issn.1673-4157.2014.01.008]
[3]王兴纯,曲伸.胰高血糖素样肽-1受体激动剂与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2014,(01):40.[doi:10.3760/cma.j.issn.1673-4157.2014.01.011]
Wang Xingchun*,Qu Shen.Glucagon like peptide-1 receptor agonist and nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(04):40.[doi:10.3760/cma.j.issn.1673-4157.2014.01.011]
[4]黄玥晔,曲伸.甲状腺激素受体：非酒精性脂肪性肝病的新靶点[J].国际内分泌代谢杂志,2014,(01):43.[doi:10.3760/cma.j.issn.1673-4157.2014.01.012]
Huang Yueye,Qu Shen.Thyroid hormone receptor：a new target of nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(04):43.[doi:10.3760/cma.j.issn.1673-4157.2014.01.012]
[5]蔡芸莹,苏恒.DPP-4在脂质代谢及非酒精性脂肪性肝病中的作用研究[J].国际内分泌代谢杂志,2014,(02):112.[doi:10.3760/cma.j.issn.1673-4157.2014.02.012]
Cai Yun-ying,Su Heng..Effects of dipeptidyl peptidase-4 on lipid metabolism and nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(04):112.[doi:10.3760/cma.j.issn.1673-4157.2014.02.012]
[6]李爱玲,谢云,李瑾,等.体重指数和腰臀比预测非酒精性脂肪性肝病发病风险的比较[J].国际内分泌代谢杂志,2014,(02):135.[doi:10.3760/cma.j.issn.1673-4157.2014.02.018]
Li Ailing,Xie Yun,Li Jin,et al.Comparison of body mass index and waist-to-hip ratio for predicting of non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(04):135.[doi:10.3760/cma.j.issn.1673-4157.2014.02.018]
[7]马卓奇 敖娜 都健.线粒体相关microRNA在非酒精性脂肪性肝病中的研究进展[J].国际内分泌代谢杂志,2019,39(05):307.[doi:10.3760/cma.j.issn.1673-4157.2019.05.005]
Ma Zhuoqi,Ao Na,Du Jian.Research progress of mitochondria-related microRNA in non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2019,39(04):307.[doi:10.3760/cma.j.issn.1673-4157.2019.05.005]
[8]张贺 杨立英 黄雯莉 王文昭 陈素凤 任路平.长链非编码RNA与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2020,40(04):241.[doi:10.3760/cma.j.issn.1673-4157.2020.04.006]
Zhang He,Yang Liying,Huang Wenli,et al.Long non-coding RNA and non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2020,40(04):241.[doi:10.3760/cma.j.issn.1673-4157.2020.04.006]
[9]倪佳英,苏青.过氧化物酶体增殖物激活受体激动剂在非酒精性脂肪性肝炎治疗中的研究进展[J].国际内分泌代谢杂志,2022,42(05):377.[doi:10.3760/cma.j.cn121383-20210407-04013]
Ni Jiaying,Su Qing..Advances of peroxisome proliferator-activated receptors agonists in the treatment of non-alcoholic steatohepatitis[J].International Journal of Endocrinology and Metabolism,2022,42(04):377.[doi:10.3760/cma.j.cn121383-20210407-04013]
[10]傅宇哲,冯文焕,张宁静,等.阻塞性睡眠呼吸暂停综合征对肥胖患者非酒精性脂肪性肝病严重程度的影响[J].国际内分泌代谢杂志,2022,42(06):505.[doi:10.3760/cma.j.cn121383-20211019-10042]
Fu Yuzhe,Feng Wenhuan,Zhang Ningjing,et al.Effect of obstructive sleep apnea syndrome on the severity of nonalcoholic fatty liver disease in patients with obesity[J].International Journal of Endocrinology and Metabolism,2022,42(04):505.[doi:10.3760/cma.j.cn121383-20211019-10042]